Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.2B
78M shares
52-week range
$16.10 – $28.99
99% from low
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Exchange
NASDAQ
CS
Borrow rate
0.30%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $105.4M | $229.7M | $344.9M | $500.6M | $786.9M | $1.09B | $1.17B | $1.29B |
| Cost of revenue | $86.0M | $184.2M | $274.8M | $388.5M | $619.6M | $849.8M | $913.9M | $984.2M |
| Gross profit | $19.4M | $45.5M | $70.1M | $112.1M | $167.3M | $238.8M | $253.4M | $304.5M |
| Gross margin | 18.4% | 19.8% | 20.3% | 22.4% | 21.3% | 21.9% | 21.7% | 23.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$3.5M | $9.7M | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | $85.3M |
| EBITDA | −$1.6M | $11.8M | $10.3M | $33.7M | $26.0M | $73.0M | $86.4M | $100.4M |
| Net income | $661.0K | −$8.6M | $46.5M | $65.8M | $30.4M | $62.0M | $54.3M | $58.5M |
| Net margin | 0.6% | -3.7% | 13.5% | 13.1% | 3.9% | 5.7% | 4.7% | 4.5% |
| EPS (diluted) | 0.01 | -0.10 | 0.47 | 0.66 | 0.30 | 0.62 | 0.57 | 0.65 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.4B | $1.30 | $1.23–$1.36 | 6 |
| 2027 | $1.5B | $1.49 | $1.37–$1.61 | 6 |
| 2028 | $1.6B | $1.64 | $1.35–$1.84 | 3 |
| 2029 | $1.7B | $1.97 | $1.93–$2.01 | 1 |
Forward consensus · source: Financial Modeling Prep
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
www.progyny.comNo one on the platform currently holds PGNY.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 812,067 | $13.8M |
| Bridgewater Associatesas of 2025-09-30 | 65,643 | $1.4M |
No one on the platform has traded PGNY yet.
| $1.2B |
| — |
| PHRPhreesia, Inc. | $10.07 | +10.30% | $622M | — |
| SDGRSchrödinger, Inc. | $16.86 | +4.46% | $1.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 50.6× earnings vs its 56.6× historical median P/E.
Fair value ≈ $32.28 · price $28.86 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
sld some winners (partial) to take profits. sld $NVMI for a 540% gain; sld $PGNY for a 30% gain;
View on StockTwits ↗$PGNY Share Price: $25.88 Contract Selected: Nov 20, 2026 $25 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.18 – $5.11 Potential Upside: 55% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$PGNY — $557K in $30C expiring 11/20 Progyny fertility benefits platform. $2.29 avg. 6 months of runway. Employer fertility benefits adoption expanding through year end. 🐂 $30 reclaim with 6 months = comfortable positioning. 🐻 Healthcare spending under macro pressure. ⚠️ $557K 6 months out. Quiet but deliberate. #hovdid 📊 Lean: BULL
View on StockTwits ↗$PGNY after da 🐑 been shook a 5/8 gap n go it was always ONTO 🐒🍌🧠⏰♾️
View on StockTwits ↗$PGNY Beauty. Bought today. Hoping for a run ip to $27 to $30.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.